Graphene Oxide in the Surgical Management of Intrabony Periodontal Defects
NCT ID: NCT05341245
Last Updated: 2022-04-22
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
6 participants
INTERVENTIONAL
2022-05-01
2023-06-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Use of Adhesion Molecule Loaded Hydrogel With Minimally Invasive Surgical Technique in Treatment of Periodontal Intrabony Defect
NCT05653245
Perforated Collagen Membrane With Nanohydroxyapatite for Intrabony Defects
NCT03399279
Evaluation of Nano-crystalline Hydroxyapatite Silica Gel in Management of Periodontal Intrabony Defects
NCT02507596
Clinical And Radiographic Evaluation Of Zinc Substituted Nanohyrdoxyappatite Bone Graft And Advanced Platelet Rich Fibrin Block In The Treatment Of Periodontal Intrabony Defects
NCT07313254
Autogenous Periosteal Pedicle Graft Versus Pericardium Membrane in Management of Periodontal Intrabony Defects in Stage III Periodontitis
NCT07111533
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Graphene oxide group
The surgical defect will be managed by open flap debridement and application of Graphene oxide
Graphene oxide and open flap debridement
Using Graphene oxide with open flap debridement in management of periodontal intrabony defects in dogs
Open flap group
The surgical defect will be managed by open flap debridement
Open flap debridement
Using Open flap debridement in management of periodontal intrabony defects in dogs
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Graphene oxide and open flap debridement
Using Graphene oxide with open flap debridement in management of periodontal intrabony defects in dogs
Open flap debridement
Using Open flap debridement in management of periodontal intrabony defects in dogs
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* 12-24 months old with approximate weight of 20-30 kg and general good health will be used
Exclusion Criteria
1 Year
2 Years
MALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ain Shams University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Zeiad Khaled
Principal investigator
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
1091
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.